Patent US4211773A successfully refreshed from Google Patents.
US4211773A
Expired / Lapsed
US
⏱️ 0.0 years remaining
5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
Assignee: Memorial Sloan Kettering Cancer Center
•
Filing: 1978-10-02
•
Granted: 1980-07-08
•
Expires: 1998-10-02
Abstract
Abstract Pyrimidine nucleosides exhibiting anti-viral and anti-tumor effects have the formula <IMAGE> wherein A is OR3, SR3, NR3R4 or NHacyl wherein R3 and R4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl; NHacyl is alkanoyl or aroyl amide; B is oxygen or sulfur; X is halogen, alkylsulfonyl or arylsulfonyl; Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R1 and R2 are the same or different and are hydrogen acyl or aroyl.
Inventors
- 👤 Carlos Lopez
- 👤 Kyoichi A. Watanabe
- 👤 Uri Reichman
- 👤 Jack J. Fox
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 14:37
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; A; A61; A61P; A61P31/00; A61P31/04; A61P31/12; A61P35/00; C07H19/12
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
272 words
Pyrimidine nucleosides having the formula ##STR7## wherein A is OR 3 , SR 3 , NR 3 R 4 or NHacyl wherein R 3 and R 4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl containing 1 to 20 carbon atoms in the alkyl portion and 6-18 carbon atoms in the aryl portion, or aryl containing 6-18 carbon atoms; NHacyl is alkanoyl containing 1-20 carbon atoms in the alkyl portion or aroyl amide selected from the group consisting of benzoyl and naphthoyl amide wherein the aromatic group may be substituted by alkyl or alkoxy of 1-20 carbon atoms, halo or nitro; B is oxygen or sulfur; X is halogen, alkylsulfonyl containing 1-20 carbon atoms in the alkyl portion or arylsulfonyl containing 6-18 carbon atoms in the aryl portion; Y is halogen, amino, monoalkyl- containing 1-20 carbon atoms in the alkyl portion or monoaralkylamino containing 1 to 20 carbon atoms in the alkyl portion and 6-18 carbon atoms in the aryl portion, dialkylamino containing 1-20 carbon atoms in the alkyl portion, aminomethyl, hydroxymethyl, lower alkyl, aryl containing 6-18 carbon atoms, aralkyl containing 1 to 20 carbon atoms in the alkyl portion and 6-18 carbon atoms in the aryl portion, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R 1 and R 2 are the same or different and are hydrogen alkanoyl containing 1-20 carbon atoms in the alkyl portion or aroyl selected from the group consisting of benzoyl and naphthoyl wherein the aromatic group may be substituted by alkyl or alkoxy of 1-20 carbon atoms, halo or nitro.
Claim 2
Dependent Claim
272 words
Pyrimidine nucleosides having the formula ##STR7## wherein A is OR 3 , SR 3 , NR 3 R 4 or NHacyl wherein R 3 and R 4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl containing 1 to 20 carbon atoms in the alkyl portion and 6-18 carbon atoms in the aryl portion, or aryl containing 6-18 carbon atoms; NHacyl is alkanoyl containing 1-20 carbon atoms in the alkyl portion or aroyl amide selected from the group consisting of benzoyl and naphthoyl amide wherein the aromatic group may be substituted by alkyl or alkoxy of 1-20 carbon atoms, halo or nitro; B is oxygen or sulfur; X is halogen, alkylsulfonyl containing 1-20 carbon atoms in the alkyl portion or arylsulfonyl containing 6-18 carbon atoms in the aryl portion; Y is halogen, amino, monoalkyl- containing 1-20 carbon atoms in the alkyl portion or monoaralkylamino containing 1 to 20 carbon atoms in the alkyl portion and 6-18 carbon atoms in the aryl portion, dialkylamino containing 1-20 carbon atoms in the alkyl portion, aminomethyl, hydroxymethyl, lower alkyl, aryl containing 6-18 carbon atoms, aralkyl containing 1 to 20 carbon atoms in the alkyl portion and 6-18 carbon atoms in the aryl portion, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R 1 and R 2 are the same or different and are hydrogen alkanoyl containing 1-20 carbon atoms in the alkyl portion or aroyl selected from the group consisting of benzoyl and naphthoyl wherein the aromatic group may be substituted by alkyl or alkoxy of 1-20 carbon atoms, halo or nitro.
Claim 3
Dependent Claim
35 words
Nucleosides of claim 1 selected from the group of 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-vinylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethynylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminocytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylaminocytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminomethylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-hydroxymethylcytosine, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine.
Claim 4
Dependent Claim
17 words
1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-azathymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-6-azathymine 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-6-azathymine,
Claim 5
Dependent Claim
17 words
1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-azathymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-6-azathymine 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-6-azathymine,
Claim 6
Dependent Claim
15 words
Nucleosides of claim 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine and 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methylcytosine.
Claim 7
Dependent Claim
44 words
Nucleosides of claim 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-vinylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethynylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylaminocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminomethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-hydroxymethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine hydrochloride, and 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine hydrochloride.
Claim 8
Dependent Claim
15 words
Nucleosides of claim 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)thymine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorouracil, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorouracil, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil and 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil.
Claim 9
Dependent Claim
23 words
Nucleosides of claim 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-azathymine, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)thymine, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-6-azathymine, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)thymine and, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-6-azathymine.
Claim 10
Dependent Claim
26 words
Pharmaceutical composition comprising a nucleoside of the formula defined in claim 1 or a pharmaceutically acceptable acid addition salts thereof together with a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim
37 words
Method of producing an anti-viral effect in a test animal which comprises administering to said animal an effective amount of a nucleoside of the formula defined in claim 1 or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim
36 words
Method of producing anti-tumor effect in a test animal which comprises administering to said animal an effective amount of a nucleoside of the formula defined in claim 1 or a pharmaceutically acceptable acid addition salt thereof.
References Cited (Backward Citations)
US3155646A
Cited
US3282921A
Cited
US3539550A
Cited
US3721664A
Cited
US3687931A
Cited
US3817982A
Cited
US3870700A
Cited
US3873516A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-07-08 | 1984-01-07 | 1984-07-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-07-08 | 1988-01-07 | 1988-07-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-07-08 | 1992-01-07 | 1992-07-08 | $7700.00 | Window Closed / Lapsed |